Opinion | China’s global initiatives offer ray of hope in a turbulent world

Top university research, cross-border data exchanges and access to mainland China’s large market have attracted Japanese firm Rohto Pharmaceutical to conduct clinical trials in Hong Kong, making it the first company from the country to partner with the city’s government under a flagship investment initiative. Rohto, known for its over-the-counter eye care and skincare products, is among the latest batch of 18 firms recruited by the Office for Attracting Strategic Enterprises (OASES), a...

China's Stock Buyback Relending Program May Expand by 200 Billion Yuan as Major State Banks Grant 100 Billion Yuan Credit Lines to Two Central SOEs BigGo Finance

Government has failed to deliver on China promises, says BIST Committee UK Parliament

Muddled China policy hurts economy and national security, say MPs The Times